GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Accounts Payable

uniQure NV (FRA:UQ1) Accounts Payable : €6.04 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is uniQure NV Accounts Payable?

uniQure NV's Accounts Payable for the quarter that ended in Dec. 2023 was €6.04 Mil.

uniQure NV's quarterly Accounts Payable declined from Jun. 2023 (€8.65 Mil) to Sep. 2023 (€5.23 Mil) but then increased from Sep. 2023 (€5.23 Mil) to Dec. 2023 (€6.04 Mil).

uniQure NV's annual Accounts Payable increased from Dec. 2021 (€2.21 Mil) to Dec. 2022 (€10.37 Mil) but then declined from Dec. 2022 (€10.37 Mil) to Dec. 2023 (€6.04 Mil).


uniQure NV Accounts Payable Historical Data

The historical data trend for uniQure NV's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

uniQure NV Accounts Payable Chart

uniQure NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.11 3.10 2.21 10.37 6.04

uniQure NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.37 8.30 8.65 5.23 6.04

uniQure NV Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


uniQure NV Accounts Payable Related Terms

Thank you for viewing the detailed overview of uniQure NV's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


uniQure NV (FRA:UQ1) Business Description

Traded in Other Exchanges
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV (FRA:UQ1) Headlines

No Headlines